pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 15·1 min read
save

Andrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement

AC Immune will be searching for a new CEO for the first time, as the company announced this week that Andrea Pfeifer plans to retire after 23 years at the helm. ...

May 15, 2026·read at Endpoints ↗

May 15, 2026 07:00 AM EDT Peer Review An­drea Pfeifer ends 23-year reign at AC Im­mune; Aca­di­a's top R&D ex­ec an­nounces re­tire­ment Alex Hoffman Copy Chief Max Gelman Senior Editor Kyle LaHucik Biotech Correspondent AC Im­mune will be search­ing for a new CEO for the first time, as the com­pa­ny an­nounced this week that An­drea Pfeifer Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
90 words · retrieved May 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AC Immune SA2
topics
Immunology2

related stories

  • Aug 20Lilly partners with Amplitude on vaccines; Otsuka scraps psychedelic trialEndpoints
  • May 13Assertio accepts new buyout bid; AI biotech Isomorphic banks $2BBioPharma Dive
  • Apr 29AbbVie faces questions about Skyrizi competition from J&JEndpoints
  • Apr 29Teva nabs experimental Tourette drug in $700M Emalex buyoutBioPharma Dive
  • Apr 28Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug developmentSTAT